222 related articles for article (PubMed ID: 30982764)
1. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
2. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.
Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H
Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443
[TBL] [Abstract][Full Text] [Related]
5. Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression.
Lin CC; Huang YK; Cho CF; Lin YS; Lo CC; Kuo TT; Tseng GC; Cheng WC; Chang WC; Hsiao TH; Lai LC; Shih JY; Liu YH; Chao KSC; Hsu JL; Lee PC; Sun X; Hung MC; Sher YP
Theranostics; 2020; 10(24):10925-10939. PubMed ID: 33042262
[No Abstract] [Full Text] [Related]
6. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis.
Zhou Q; Andersson R; Hu D; Bauden M; Sasor A; Bygott T; PawŁowski K; Pla I; Marko-Varga G; Ansari D
Transl Res; 2019 Oct; 212():67-79. PubMed ID: 31295437
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
9. BASP1 is up-regulated in tongue squamous cell carcinoma and associated with a poor prognosis.
Li Y; Wu T; Jiao Z; Yang A
Asian J Surg; 2022 May; 45(5):1101-1106. PubMed ID: 34531104
[TBL] [Abstract][Full Text] [Related]
10. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
12. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.
Carpenter B; Hill KJ; Charalambous M; Wagner KJ; Lahiri D; James DI; Andersen JS; Schumacher V; Royer-Pokora B; Mann M; Ward A; Roberts SG
Mol Cell Biol; 2004 Jan; 24(2):537-49. PubMed ID: 14701728
[TBL] [Abstract][Full Text] [Related]
13. WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line.
Goodfellow SJ; Rebello MR; Toska E; Zeef LA; Rudd SG; Medler KF; Roberts SG
Biochem J; 2011 Apr; 435(1):113-25. PubMed ID: 21269271
[TBL] [Abstract][Full Text] [Related]
14. Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
Mundt F; Johansson HJ; Forshed J; Arslan S; Metintas M; Dobra K; Lehtiö J; Hjerpe A
Mol Cell Proteomics; 2014 Mar; 13(3):701-15. PubMed ID: 24361865
[TBL] [Abstract][Full Text] [Related]
15. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract][Full Text] [Related]
16. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
17. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
[TBL] [Abstract][Full Text] [Related]
18. BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/
Li L; Meng Q; Li G; Zhao L
Biomed Res Int; 2020; 2020():8628695. PubMed ID: 33426068
[TBL] [Abstract][Full Text] [Related]
19. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
20. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
